文献速递胃肠外科围术期管理与 ERAS

机器人辅助与腹腔镜结直肠手术随机试验的经济报告与利益冲突:一项元流行病学系统综述

Economic reporting and conflicts of interest in randomized trials comparing robot-assisted with laparoscopic colorectal surgery: A metaepidemiological systematic review.
PubMed 文献 · Surgery · 2026-08-05

7/15项试验(46.7%;95%CI 21.3-73.4)报告了任何成本数据,仅2/15项(13.3%)进行了正式经济学评价,且均未引用CHEERS标准。报告成本的试验中机器人手术均更昂贵,但两项正式评价结论相反;仅少数试验有计划的经济结局预设。

要点

  • 结直肠手术随机试验中经济结局报告不一致,仅46.7%报告任何成本数据。
  • 仅13.3%试验进行正式经济学评价,均未遵循CHEERS报告标准。
  • 报告成本的试验中机器人手术均更贵,但两项正式评价结论相反。

核心结论

  • 在这些平台试验中,经济结局的报告不一致。
  • 若拟进行经济学评价,预设成本结局并遵循CHEERS等标准可提高其对决策者的实用性。

研究设计与样本

  • 元流行病学系统综述(PROSPERO: CRD420261411610),检索PubMed、Embase和Cochrane CENTRAL。
  • 以试验为主要分析单位,比例采用精确95%置信区间估计,描述 funding-reporting 关系。

主要发现

  • 7/15项试验(46.7%;95%CI 21.3-73.4)报告了任何成本数据。
  • 2/15项试验(13.3%)进行了正式经济学评价,均未引用CHEERS标准。
  • 4项试验有注册或方案记录的经济结局(2项已报告,2项推迟);大多数未报告成本的试验未计划经济结局。
  • 报告成本的试验中机器人手术均更昂贵,但比较范围和证据强度差异很大;两项正式评价结论相反。
  • 2项试验由制造商资助,4项试验作者存在利益冲突;关联估计不精确,不足以推断。

临床怎么用

  • 解读机器人结直肠手术试验时需注意经济结局报告不一致且常无预设。
  • 决策者应谨慎对待未预设或未经正式评价的成本数据。
  • 未来试验若拟评价经济性,应预设成本结局并遵循CHEERS标准。

局限性

  • 利益冲突与资助的关联估计不精确,不足以推断。
  • 报告成本的试验间比较范围和证据强度差异很大。
  • 两项正式经济学评价结论相反,提示经济证据尚不确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted colorectal surgery carries a substantial cost premium, yet how consistently randomized trials of these platforms report economic outcomes-and whether reporting relates to industry funding or conflicts of interest-is unclear. METHODS: We conducted a metaepidemiological systematic review (PROSPERO: CRD420261411610), searching PubMed, Embase, and Cochrane CENTRAL for randomized controlled trials comparing robot-assisted with conventional laparoscopic colorectal surgery. Reports were classified by cost-reporting tier (tier 1, none; tier 2, cost data without a formal economic evaluation; and tier 3, formal economic evaluation with an incremental cost-effectiveness ratio or quality-adjusted life-years); registries and protocols were checked for prespecified economic outcomes. The trial was the primary unit; proportions were estimated with exact 95% confidence intervals, and funding-reporting relationships were described. RESULTS: Twenty-three reports of 15 trials were included. Any cost data were reported by 7 of 15 trials (46.7%; 95% confidence interval, 21.3-73.4) and a formal economic evaluation by 2 of 15 (13.3%); neither cited the Consolidated Health Economic Evaluation Reporting Standards. Four trials had a registered or protocol-documented economic outcome (2 reported, 2 deferred); most reporting no cost had not planned one. Robotic surgery was costlier in every trial reporting cost, although the scope and evidentiary strength of these comparisons varied substantially; the 2 formal evaluations reached opposite conclusions. Two trials were manufacturer funded, and 4 trials had author conflicts of interest; associations were too imprecise for inference. CONCLUSION: Within these platform trials, economic outcomes were reported inconsistently. When an economic evaluation is intended, prespecifying a cost outcome and following a standard such as Consolidated Health Economic Evaluation Reporting Standards would improve its usefulness for decision-makers.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Choi SJ, Chae G. Economic reporting and conflicts of interest in randomized trials comparing robot-assisted with laparoscopic colorectal surgery: A metaepidemiological systematic review. Surgery. 2026. PMID: 42642296. doi:10.1016/j.surg.2026.110509

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。